These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 21153520)
1. Complement activation by phospholipids: the interplay of factor H and C1q. Tan LA; Yu B; Sim FC; Kishore U; Sim RB Protein Cell; 2010 Nov; 1(11):1033-49. PubMed ID: 21153520 [TBL] [Abstract][Full Text] [Related]
2. Interactions of complement proteins C1q and factor H with lipid A and Escherichia coli: further evidence that factor H regulates the classical complement pathway. Tan LA; Yang AC; Kishore U; Sim RB Protein Cell; 2011 Apr; 2(4):320-32. PubMed ID: 21574022 [TBL] [Abstract][Full Text] [Related]
3. Factor H as a regulator of the classical pathway activation. Kishore U; Sim RB Immunobiology; 2012 Feb; 217(2):162-8. PubMed ID: 21852018 [TBL] [Abstract][Full Text] [Related]
4. Complement-Coagulation Cross-talk: Factor H-mediated regulation of the Complement Classical Pathway activation by fibrin clots. Kang YH; Varghese PM; Aiyan AA; Pondman K; Kishore U; Sim RB Front Immunol; 2024; 15():1368852. PubMed ID: 38933264 [TBL] [Abstract][Full Text] [Related]
5. Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly. Sjöberg AP; Nyström S; Hammarström P; Blom AM Mol Immunol; 2008 Jun; 45(11):3213-21. PubMed ID: 18406463 [TBL] [Abstract][Full Text] [Related]
6. Highly specific inhibition of C1q globular-head binding to human IgG: a novel approach to control and regulate the classical complement pathway using an engineered single chain antibody variable fragment. Hwang HY; Duvall MR; Tomlinson S; Boackle RJ Mol Immunol; 2008 May; 45(9):2570-80. PubMed ID: 18313756 [TBL] [Abstract][Full Text] [Related]
7. The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q. Sjöberg A; Onnerfjord P; Mörgelin M; Heinegård D; Blom AM J Biol Chem; 2005 Sep; 280(37):32301-8. PubMed ID: 16046396 [TBL] [Abstract][Full Text] [Related]
8. A recombinant homotrimer, composed of the alpha helical neck region of human surfactant protein D and C1q B chain globular domain, is an inhibitor of the classical complement pathway. Kishore U; Strong P; Perdikoulis MV; Reid KB J Immunol; 2001 Jan; 166(1):559-65. PubMed ID: 11123337 [TBL] [Abstract][Full Text] [Related]
9. C1q A08 Is a Half-Cryptic Epitope of Anti-C1q A08 Antibodies in Lupus Nephritis and Important for the Activation of Complement Classical Pathway. Wu WJ; Tan Y; Liu XL; Yu F; Zhao MH Front Immunol; 2020; 11():848. PubMed ID: 32536911 [TBL] [Abstract][Full Text] [Related]
10. High molecular weight non-immunoglobulin salivary agglutinins (NIA) bind C1Q globular heads and have the potential to activate the first complement component. Boackle RJ; Connor MH; Vesely J Mol Immunol; 1993 Feb; 30(3):309-19. PubMed ID: 8433709 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E Triggers Complement Activation in Joint Synovial Fluid of Rheumatoid Arthritis Patients by Binding C1q. Vogt LM; Kwasniewicz E; Talens S; Scavenius C; Bielecka E; Ekdahl KN; Enghild JJ; Mörgelin M; Saxne T; Potempa J; Blom AM J Immunol; 2020 May; 204(10):2779-2790. PubMed ID: 32253242 [TBL] [Abstract][Full Text] [Related]
12. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q. Jiang HX; Siegel JN; Gewurz H J Immunol; 1991 Apr; 146(7):2324-30. PubMed ID: 2005402 [TBL] [Abstract][Full Text] [Related]
13. Rat polymeric IgA binds C1q, but does not activate C1. Hiemstra PS; Rits M; Gorter A; Stuurman ME; Hoekzema R; Bazin H; Vaerman JP; van Es LA; Daha MR Mol Immunol; 1990 Sep; 27(9):867-74. PubMed ID: 2215479 [TBL] [Abstract][Full Text] [Related]
14. Heme interacts with c1q and inhibits the classical complement pathway. Roumenina LT; Radanova M; Atanasov BP; Popov KT; Kaveri SV; Lacroix-Desmazes S; Frémeaux-Bacchi V; Dimitrov JD J Biol Chem; 2011 May; 286(18):16459-69. PubMed ID: 21454703 [TBL] [Abstract][Full Text] [Related]
15. C1q binding to liposomes is surface charge dependent and is inhibited by peptides consisting of residues 14-26 of the human C1qA chain in a sequence independent manner. Bradley AJ; Brooks DE; Norris-Jones R; Devine DV Biochim Biophys Acta; 1999 Apr; 1418(1):19-30. PubMed ID: 10209207 [TBL] [Abstract][Full Text] [Related]
16. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Nauta AJ; Trouw LA; Daha MR; Tijsma O; Nieuwland R; Schwaeble WJ; Gingras AR; Mantovani A; Hack EC; Roos A Eur J Immunol; 2002 Jun; 32(6):1726-36. PubMed ID: 12115656 [TBL] [Abstract][Full Text] [Related]
17. Studies on the interactions between C-reactive protein and complement proteins. Bíró A; Rovó Z; Papp D; Cervenak L; Varga L; Füst G; Thielens NM; Arlaud GJ; Prohászka Z Immunology; 2007 May; 121(1):40-50. PubMed ID: 17244159 [TBL] [Abstract][Full Text] [Related]
18. Functional characterization of a recombinant form of the C-terminal, globular head region of the B-chain of human serum complement protein, C1q. Kishore U; Leigh LE; Eggleton P; Strong P; Perdikoulis MV; Willis AC; Reid KB Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):27-32. PubMed ID: 9639558 [TBL] [Abstract][Full Text] [Related]
19. Specific inhibition of the classical complement pathway by C1q-binding peptides. Roos A; Nauta AJ; Broers D; Faber-Krol MC; Trouw LA; Drijfhout JW; Daha MR J Immunol; 2001 Dec; 167(12):7052-9. PubMed ID: 11739526 [TBL] [Abstract][Full Text] [Related]
20. Prion protein activates and fixes complement directly via the classical pathway: implications for the mechanism of scrapie agent propagation in lymphoid tissue. Mitchell DA; Kirby L; Paulin SM; Villiers CL; Sim RB Mol Immunol; 2007 Apr; 44(11):2997-3004. PubMed ID: 17337056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]